{"title":"Original Articles","authors":"Asmiha Indonesian Heart Association","doi":"10.30701/ijc.1074","DOIUrl":"https://doi.org/10.30701/ijc.1074","url":null,"abstract":"Abstracts of the 29th Annual Scientific Meeting of the Indonesian Heart Association (ASMIHA) \u00001st ASMIHA Digital Conference, 23-25 October 2020","PeriodicalId":32916,"journal":{"name":"Majalah Kardiologi Indonesia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41255578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Abstracts of the 29th Annual Scientific Meeting of the Indonesian Heart Association (ASMIHA) 1st ASMIHA Digital Conference, 23-25 October 2020
2020年10月23日至25日，印度尼西亚心脏协会（ASMIHA）第29届年度科学会议摘要
{"title":"Young Investigators Award Session","authors":"Asmiha Indonesian Heart Association","doi":"10.30701/ijc.1077","DOIUrl":"https://doi.org/10.30701/ijc.1077","url":null,"abstract":"Abstracts of the 29th Annual Scientific Meeting of the Indonesian Heart Association (ASMIHA) \u00001st ASMIHA Digital Conference, 23-25 October 2020","PeriodicalId":32916,"journal":{"name":"Majalah Kardiologi Indonesia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47925652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-08-31DOI: 10.29328/journal.jccm.1001102
G. Datta
Background: Mechanical revascularization of the infarct-related artery (IRA) is the most effective treatment modality in ST-segment elevation myocardial infarction (STEMI).No flow occurs in ∼8.8-10% of cases of primary percutaneous coronary intervention(PCI) in STEMI patients. Our aim was to study actual incidence and outcome of no flow patients. Methods: Five hundred and eighty primary PCI patients were studied over a period of two years i.e. January 2016 to December 2017. Drug eluting stents were used in all cases. Majority of our patients(>90%) came 6 hours after onset of chest pain. There were many patients where there was no flow even after mechanical thrombus aspiration and pharmacological vasodilator therapy. We have studied primary outcome(mortality) of no flow in those patients. Results: There were 44 cases of no flow in our series(7.75%). Left anterior descending artery(LAD )was involved in eighteen patients. Right coronary artery(RCA) was culprit in twenty four cases. Only two cases were seen in LCX territory. One month mortality rate in no flow group was 50% and 6.25% in successful recanalization group. One year mortality was 12.5% in successful recanalization group and 66% in no flow group. Conclusion: Refractory no flow during primary PCI in STEMI is associated with high mortality and morbidity. There is no established strategy to solve this phenomenon.
{"title":"Incidence and outcome of no flow after primary percutaneous coronary intervention in acute myocardial infarction","authors":"G. Datta","doi":"10.29328/journal.jccm.1001102","DOIUrl":"https://doi.org/10.29328/journal.jccm.1001102","url":null,"abstract":" \u0000Background: Mechanical revascularization of the infarct-related artery (IRA) \u0000is the most effective treatment modality in ST-segment elevation myocardial \u0000infarction (STEMI).No flow occurs in ∼8.8-10% of cases of primary \u0000percutaneous coronary intervention(PCI) in STEMI patients. Our aim was to study \u0000actual incidence and outcome of no flow patients. \u0000Methods: Five hundred and eighty primary PCI patients \u0000were studied over a period of two years i.e. January 2016 to December 2017. \u0000Drug eluting stents were used in all cases. Majority of our patients(>90%) came 6 \u0000hours after onset of chest pain. There were many patients where there was \u0000no flow even after mechanical thrombus aspiration and pharmacological \u0000vasodilator therapy. We have studied primary outcome(mortality) of no flow in \u0000those patients. \u0000Results: There were 44 cases of no flow in our \u0000series(7.75%). Left anterior descending artery(LAD )was involved in eighteen \u0000patients. Right coronary artery(RCA) was culprit in twenty four cases. Only \u0000two cases were seen in LCX territory. One month mortality rate in no flow group \u0000was 50% and 6.25% in successful recanalization group. One year mortality was \u000012.5% in successful recanalization group and 66% in no flow group. \u0000Conclusion: Refractory no flow during primary PCI in STEMI is associated \u0000with high mortality and morbidity. There is no established strategy to solve \u0000this phenomenon. \u0000 \u0000 ","PeriodicalId":32916,"journal":{"name":"Majalah Kardiologi Indonesia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49432119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Age-related change in autonomic nerves covers parasympathetic function decrease that hampers heart rate (HR) control. The effective attempt to improve autonomic nervous function for elderly is routine exercise, however exercise duration among elderly is not always standardized. This study is aimed to compare the effect of different exercise duration to post-exercise Heart Rate Recovery (HRR) between two elderly groups with the same frequency, intensity, type criteria of routine exercise. Methods: Method was cross-sectional study which compared exercise duration of standardized group (3x90 minutes/week) and unstandardized group (3x30 minutes/week). Group 1 was elders with standardized duration from Healthy Heart Club and Group 2 was elders who take unstandardized duration from Elderly Home in Bandung city. Each group consisted of 43 elders and data were collected in July-August 2019. After one hour of medium intensity exercise, all respondents were examined for resting HR (HRrest), maximum HR (HRmax), one minute post-exercise HR, and four minutes post-exercise HR. HRR was obtained by subtracting HRmax by one minute post-exercise HR and normal if > 12 bpm. Analysis data was done by SPSS with Mann-Whitney U Test, Fisher Chi Square and Logistic regression. Results: Most of respondents were 60-69 years old and female. Respondents in unstandardized group were more low education, hypertension and smoking. The HRrest of both groups was categorized as normal but increased greater (30x/min) in standardized group. The result showed a significant difference in comparation of median HRR (p=0.001) and number of normal and abnormal HRR (p=0.001) between both groups. Gender, smoking and standardized duration of exercise associated with abnormality of HRR, elders who take unstandardized duration have 12.7 times risk to get abnormal HRR. Conclusion: Routine exercise for elderly is recommended in standardized duration with minimal 150 minutes per week in order to increase post-exercise HRR. (Indonesian J Cardiol. 2020;41:17-24)
{"title":"Effect of Exercise Duration Toward Heart Rate Recovery in Elderly","authors":"Arie Ramdhiani Mahassa, M. R. Akbar, S. Y. Sari","doi":"10.30701/IJC.1025","DOIUrl":"https://doi.org/10.30701/IJC.1025","url":null,"abstract":"Background: Age-related change in autonomic nerves covers parasympathetic function decrease that hampers heart rate (HR) control. The effective attempt to improve autonomic nervous function for elderly is routine exercise, however exercise duration among elderly is not always standardized. This study is aimed to compare the effect of different exercise duration to post-exercise Heart Rate Recovery (HRR) between two elderly groups with the same frequency, intensity, type criteria of routine exercise. Methods: Method was cross-sectional study which compared exercise duration of standardized group (3x90 minutes/week) and unstandardized group (3x30 minutes/week). Group 1 was elders with standardized duration from Healthy Heart Club and Group 2 was elders who take unstandardized duration from Elderly Home in Bandung city. Each group consisted of 43 elders and data were collected in July-August 2019. After one hour of medium intensity exercise, all respondents were examined for resting HR (HRrest), maximum HR (HRmax), one minute post-exercise HR, and four minutes post-exercise HR. HRR was obtained by subtracting HRmax by one minute post-exercise HR and normal if > 12 bpm. Analysis data was done by SPSS with Mann-Whitney U Test, Fisher Chi Square and Logistic regression. Results: Most of respondents were 60-69 years old and female. Respondents in unstandardized group were more low education, hypertension and smoking. The HRrest of both groups was categorized as normal but increased greater (30x/min) in standardized group. The result showed a significant difference in comparation of median HRR (p=0.001) and number of normal and abnormal HRR (p=0.001) between both groups. Gender, smoking and standardized duration of exercise associated with abnormality of HRR, elders who take unstandardized duration have 12.7 times risk to get abnormal HRR. Conclusion: Routine exercise for elderly is recommended in standardized duration with minimal 150 minutes per week in order to increase post-exercise HRR. (Indonesian J Cardiol. 2020;41:17-24)","PeriodicalId":32916,"journal":{"name":"Majalah Kardiologi Indonesia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41589754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Badai Bhatara Tiksnadi, Nova Sylviana, Adityo Cahyadi, Alberta Claudia Undarsa
Hipertensi merupakan salah satu komorbid yang paling banyak ditemukan pada Coronavirus disease-19 (COVID-19) dan berasosiasi dengan prognostik buruk dari infeksi tersebut. Olahraga rutin ternyata dapat meningkatkan imunitas tubuh, sehingga dapat berperan dalam pencegahan infeksi COVID-19 selain efeknya terhadap penurunan tekanan darah. Olahraga tipe aerobik dengan intensitas sedang 30-60 menit, dengan cara tetap melakukan pembatasan jarak, ataupun dengan teknik home exercise dan virtual dengan daring, dapat dilakukan oleh penderita hipertensi dalam meningkatkan imunitas selama masa pandemi COVID-19.
{"title":"Olahraga Rutin Untuk Meningkatkan Imunitas Pasien Hipertensi Selama Masa Pandemi COVID-19","authors":"Badai Bhatara Tiksnadi, Nova Sylviana, Adityo Cahyadi, Alberta Claudia Undarsa","doi":"10.30701/IJC.1016","DOIUrl":"https://doi.org/10.30701/IJC.1016","url":null,"abstract":"Hipertensi merupakan salah satu komorbid yang paling banyak ditemukan pada Coronavirus disease-19 (COVID-19) dan berasosiasi dengan prognostik buruk dari infeksi tersebut. Olahraga rutin ternyata dapat meningkatkan imunitas tubuh, sehingga dapat berperan dalam pencegahan infeksi COVID-19 selain efeknya terhadap penurunan tekanan darah. Olahraga tipe aerobik dengan intensitas sedang 30-60 menit, dengan cara tetap melakukan pembatasan jarak, ataupun dengan teknik home exercise dan virtual dengan daring, dapat dilakukan oleh penderita hipertensi dalam meningkatkan imunitas selama masa pandemi COVID-19.","PeriodicalId":32916,"journal":{"name":"Majalah Kardiologi Indonesia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46849024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Manifestasi kardiovaskular berupa injuri miokard, dapat timbul pada pasien yang terinfeksi COVID-19. Data yang dikumpulkan dari berbagai laporan kasus pandemi COVID-19 menunjukkan bahwa laki-laki lebih sering mengalami injuri miokard dibandingkan perempuan. Hingga saat ini belum ditemukan mekanisme pasti yang mendasari kerentanan untuk mengalami injuri miokard akibat terinfeksi SARS-CoV-2 karena perbedaan gender. Beberapa teori yang diajukan adalah perbedaan jumlah kromosom X, pengaruh hormon seks dan perbedaan reaksi imun antara laki-laki dan perempuan. Perlu dilakukan penelitian lanjutan yang lebih mendalam tentang mekanisme manifestasi kardiovaskular dan pengaruh gender pada penyakit COVID-19. Kata kunci: Gender, manifestasi kardiovaskular, injuri miokard, COVID-19.
{"title":"Pengaruh Gender dan Manifestasi Kardiovaskular Pada COVID-19","authors":"Dyana Sarvasti","doi":"10.30701/ijc.1004","DOIUrl":"https://doi.org/10.30701/ijc.1004","url":null,"abstract":"Manifestasi kardiovaskular berupa injuri miokard, dapat timbul pada pasien yang terinfeksi COVID-19. Data yang dikumpulkan dari berbagai laporan kasus pandemi COVID-19 menunjukkan bahwa laki-laki lebih sering mengalami injuri miokard dibandingkan perempuan. Hingga saat ini belum ditemukan mekanisme pasti yang mendasari kerentanan untuk mengalami injuri miokard akibat terinfeksi SARS-CoV-2 karena perbedaan gender. Beberapa teori yang diajukan adalah perbedaan jumlah kromosom X, pengaruh hormon seks dan perbedaan reaksi imun antara laki-laki dan perempuan. Perlu dilakukan penelitian lanjutan yang lebih mendalam tentang mekanisme manifestasi kardiovaskular dan pengaruh gender pada penyakit COVID-19. \u0000Kata kunci: Gender, manifestasi kardiovaskular, injuri miokard, COVID-19.","PeriodicalId":32916,"journal":{"name":"Majalah Kardiologi Indonesia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41547898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. E. Tondas, Rolando Agustian Halim, Moza Guyanto
At the end of year 2019, the world faced an outbreak of a highly virulent novel Coronavirus disease (COVID-19), which changed the way physicians, including cardiologists, do their routine clinical practice. As distance limitation and efficient use of personal protective devices must be employed to prevent the pandemic spreading, even simple electrocardiogram (ECG) taking that involves directly placing electrode leads on a patient’s body may become riskier. This review will discuss the possibility of minimal or no touch EKG using the latest wireless technologies, beneficial in monitoring COVID-19 patients for cardiovascular problems or patients who seek cardiac care, but with posing risk of concomitant COVID-19. (Indonesian J Cardiol. 2020;41:133-141) Keyword: COVID-19, SARS-CoV-2, physical distancing, electrocardiogram, heart rhythm monitoring 1 Biomedicine Doctoral Program, Faculty of Medicine, Universitas Sriwijaya, Palembang, Indonesia 2 Cardiology & Vascular Medicine Department, Mohammad Hoesin General Hospital, Palembang,
{"title":"Minimal or No Touch Electrocardiography Recording and Remote Heart Rhythm Monitoring during COVID-19 Pandemic Era","authors":"A. E. Tondas, Rolando Agustian Halim, Moza Guyanto","doi":"10.30701/ijc.1010","DOIUrl":"https://doi.org/10.30701/ijc.1010","url":null,"abstract":"At the end of year 2019, the world faced an outbreak of a highly virulent novel Coronavirus disease (COVID-19), which changed the way physicians, including cardiologists, do their routine clinical practice. As distance limitation and efficient use of personal protective devices must be employed to prevent the pandemic spreading, even simple electrocardiogram (ECG) taking that involves directly placing electrode leads on a patient’s body may become riskier. This review will discuss the possibility of minimal or no touch EKG using the latest wireless technologies, beneficial in monitoring COVID-19 patients for cardiovascular problems or patients who seek cardiac care, but with posing risk of concomitant COVID-19. (Indonesian J Cardiol. 2020;41:133-141) Keyword: COVID-19, SARS-CoV-2, physical distancing, electrocardiogram, heart rhythm monitoring 1 Biomedicine Doctoral Program, Faculty of Medicine, Universitas Sriwijaya, Palembang, Indonesia 2 Cardiology & Vascular Medicine Department, Mohammad Hoesin General Hospital, Palembang,","PeriodicalId":32916,"journal":{"name":"Majalah Kardiologi Indonesia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46432574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Coronavirus disease (COVID-19) caused by infection of SARS-CoV-2 as of April 2020 has been confirmed in more than 2.3 million people, with more than 150 thousands deaths across the globe. It has been known that COVID-19 patients with underlying cardiovascular diseases and its risks including: hypertension, diabetes, coronary artery disease, and cerebrovascular diseases may develop more severe respiratory track symptoms requiring intensive care. Some patients may presenting with myocarditis or acute cardiomyopathy, which has high mortality and morbidity. There was also evidence of myocardial Injury with an increase of troponin in one-third of those infected by covid-19. It is conceivable that among those who recover from COVID-19 infection, there is a risk of developing further cardiomypathy once the pandemic receding in the future. It is important to pay attention to this survivor group since the pandemic may be lasting for longer period. Optimal medical treatment and comprehensive prevention should be taken to manage those high risk patients of developing cardiomyopathy during hospital care as well post discharge. These includes provide best available COVID-19 drugs, cardiovascular medications, and social preventive measures.
{"title":"Cardiomyopathy in Coronavirus Disease Survivors: Mechanism, Management and Prevention","authors":"R. Sukmawan","doi":"10.30701/ijc.1012","DOIUrl":"https://doi.org/10.30701/ijc.1012","url":null,"abstract":"Coronavirus disease (COVID-19) caused by infection of SARS-CoV-2 as of April 2020 has been confirmed in more than 2.3 million people, with more than 150 thousands deaths across the globe. It has been known that COVID-19 patients with underlying cardiovascular diseases and its risks including: hypertension, diabetes, coronary artery disease, and cerebrovascular diseases may develop more severe respiratory track symptoms requiring intensive care. Some patients may presenting with myocarditis or acute cardiomyopathy, which has high mortality and morbidity. There was also evidence of myocardial Injury with an increase of troponin in one-third of those infected by covid-19. It is conceivable that among those who recover from COVID-19 infection, there is a risk of developing further cardiomypathy once the pandemic receding in the future. It is important to pay attention to this survivor group since the pandemic may be lasting for longer period. Optimal medical treatment and comprehensive prevention should be taken to manage those high risk patients of developing cardiomyopathy during hospital care as well post discharge. These includes provide best available COVID-19 drugs, cardiovascular medications, and social preventive measures.","PeriodicalId":32916,"journal":{"name":"Majalah Kardiologi Indonesia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43730708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) yang dikenal dengan COVID-19 adalah penyakit yang baru dan telah menyebar dengan cepat dari Wuhan (provinsi Hubei) ke provinsi lain di Cina dan seluruh dunia termasuk Indonesia. Secara umum, COVID-19 adalah penyakit akut yang bisa sembuh tetapi juga mematikan, dengan case fatality rate (CFR) sebesar 4%. Spektrum klinis pneumonia COVID-19 berkisar dari kondisi ringan sampai dengan berat. COVID 19 diduga memiliki risiko potensiasi proses patofisiologi terhadap timbulnya komplikasi kardiak, dan telah diketahui bahwa mekanisme penyakit kardiovaskular serupa dengan mekanisme jalur imunologi. Penyakit kardiovaskular adalah komorbid terbanyak pada pasien COVID 19, SARS, dan MERS. Prevalensi diabetes mellitus (DM) dan penyakit kardiovaskular pada SARS adalah 11% dan 8% dan membawa angka kematian meningkat 2 kali lipat. Pada kasus COVID 19, komorbid penyakit kardiovaskular lebih banyak menunjukkan kasus yang berat. Bagaimana mekanisme komorbid ini memperburuk keluaran pasien masih tidak jelas, namun beberapa hipotesisnya antara lain usia lanjut, gangguan sistem imun, peningkatan kadar ACE2 atau mungkin ada hubungan antara COVID 19 dengan penyakit kardiovaskular. Tinjauan pustaka ini akan menjelaskan berbagai gangguan kardiovaskular yang mungkin terjadi pada infeksi COVID 19 secara lebih mendalam.
{"title":"Gangguan Kardiovaskular pada infeksi COVID 19","authors":"Dian Hasanah, Siti Elkana Nauli, Vebiona Kartini Prima Putri, Habibie Arifianto, Nanang Suryana, Lita Dwi Suryani, Wahyu Aditya, Paskariatne Probodewi","doi":"10.30701/ijc.v1i1.994","DOIUrl":"https://doi.org/10.30701/ijc.v1i1.994","url":null,"abstract":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) yang dikenal dengan COVID-19 adalah penyakit yang baru dan telah menyebar dengan cepat dari Wuhan (provinsi Hubei) ke provinsi lain di Cina dan seluruh dunia termasuk Indonesia. Secara umum, COVID-19 adalah penyakit akut yang bisa sembuh tetapi juga mematikan, dengan case fatality rate (CFR) sebesar 4%. Spektrum klinis pneumonia COVID-19 berkisar dari kondisi ringan sampai dengan berat. COVID 19 diduga memiliki risiko potensiasi proses patofisiologi terhadap timbulnya komplikasi kardiak, dan telah diketahui bahwa mekanisme penyakit kardiovaskular serupa dengan mekanisme jalur imunologi. Penyakit kardiovaskular adalah komorbid terbanyak pada pasien COVID 19, SARS, dan MERS. Prevalensi diabetes mellitus (DM) dan penyakit kardiovaskular pada SARS adalah 11% dan 8% dan membawa angka kematian meningkat 2 kali lipat. Pada kasus COVID 19, komorbid penyakit kardiovaskular lebih banyak menunjukkan kasus yang berat. Bagaimana mekanisme komorbid ini memperburuk keluaran pasien masih tidak jelas, namun beberapa hipotesisnya antara lain usia lanjut, gangguan sistem imun, peningkatan kadar ACE2 atau mungkin ada hubungan antara COVID 19 dengan penyakit kardiovaskular. Tinjauan pustaka ini akan menjelaskan berbagai gangguan kardiovaskular yang mungkin terjadi pada infeksi COVID 19 secara lebih mendalam. \u0000 ","PeriodicalId":32916,"journal":{"name":"Majalah Kardiologi Indonesia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46863904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The coronavirus disease-2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) that first appeared in Wuhan, China. COVID-19 was found to have significant connection with the cardiovascular system by causing complications such as myocarditis and arrhythmias. Furthermore, medications for COVID-19 have been shown to induce cardiovascular side effects. The emergence of COVID-19 spreading also raised questions on the need for modification of life support algorithms to protect vulnerable healthcare workers.
{"title":"Cardiovascular Implications of Coronavirus Disease 2019","authors":"Rissa U. Setiani","doi":"10.30701/ijc.v1i1.1008","DOIUrl":"https://doi.org/10.30701/ijc.v1i1.1008","url":null,"abstract":"The coronavirus disease-2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) that first appeared in Wuhan, China. COVID-19 was found to have significant connection with the cardiovascular system by causing complications such as myocarditis and arrhythmias. Furthermore, medications for COVID-19 have been shown to induce cardiovascular side effects. The emergence of COVID-19 spreading also raised questions on the need for modification of life support algorithms to protect vulnerable healthcare workers. \u0000 ","PeriodicalId":32916,"journal":{"name":"Majalah Kardiologi Indonesia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48688644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：